Filing Details
- Accession Number:
- 0000950170-25-063792
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-05 19:18:48
- Reporting Period:
- 2025-04-21
- Filing Date:
- 2025-05-05
- Accepted Time:
- 2025-05-05 19:18:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1515673 | Ultragenyx Pharmaceutical Inc. | RARE | Pharmaceutical Preparations (2834) | 272546083 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1653052 | Eric Crombez | C/O Ultragenyx Pharmaceutical Inc. 60 Leveroni Court Novato CA 94949 | Evp And Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-04-21 | 242 | $35.11 | 71,680 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-05-05 | 520 | $39.24 | 71,530 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
- Includes 370 shares acquired on April 30, 2025 under the Company's Amended and Restated Employee Stock Purchase Plan
- Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Billionaire Hedge Funds
